3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
50
Prostatic Neoplasms
23
Lung Neoplasms
17
Breast Neoplasms
16
Squamous Cell Carcinoma of Head and Neck
13
Neoplasms
9
Stomach Neoplasms
8
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Neoplasm Metastasis
6
Head and Neck Neoplasms
6
Carcinoma, Transitional Cell
6
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Non-Muscle Invasive Bladder Neoplasms
5
Endometrial Neoplasms
5
Carcinoma, Squamous Cell
5
Prostatic Neoplasms, Castration-Resistant
4
Oropharyngeal Neoplasms
4
Small Cell Lung Carcinoma
3
Ovarian Neoplasms
3
Nasopharyngeal Carcinoma
3
HER2-positive Breast Cancer
3
Esophageal Squamous Cell Carcinoma
3
Carcinoma
3
Anatomic Stage I Breast Cancer AJCC v8
3
Adenocarcinoma
3
Vaccinia
2
Solid Tumors
2
Sarcoma
2
Salivary Gland Neoplasms
2
Interventions
fludarabine
1
aldesleukin
1
Cyclophosphamide
1
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Adenosquamous
×
Docetaxel
×
90 days
×
Clear all
No trials found.